Form EFFECT Eloxx Pharmaceuticals,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 18, 2026 4:15 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Leerink Starts Eloxx Pharma (ELOX) at Outperform
- BNB News: A Dime in 2017 Became More Than $780—Could Remittix Be the Best Crypto Presale to Buy Before the Next Breakout?
- Edward Jones and the Alzheimer's Association® Celebrate More Than a Decade of Impact on World Alzheimer's Day
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share